Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Lomustine (CCNU) in Veterinary Oncology: Delayed-Toxicity Safety Profile
Lomustine, also called CCNU, is an oral nitrosourea chemotherapy drug used by veterinary oncologists for selected cancers. Use in dogs and cats is generally extra-label and requires a…
Read more
Omega-3 Fatty Acid Support: Product, Dose, and Evidence Questions
Omega-3 products are nutritional supplements, not cancer treatments. EPA and DHA content, total calories, oxidation control, formulation, and quality vary widely, and evidence from one condition or diet…
Read moreMetronomic Chemotherapy: Goal, Evidence, and Handling Boundary
Metronomic therapy uses regularly scheduled cytotoxic medication in selected plans; it remains prescription hazardous-drug treatment and is not simply gentle chemotherapy.
Read moreHome Handling of Oral Chemotherapy and Patient Waste
Families need drug-specific written instructions for receiving, storing, administering, cleaning, laundering, and disposing of chemotherapy and contaminated patient waste.
Read more
Medicinal Mushroom Extracts: Product-Specific Oncology Evidence
Mushroom products differ by species, extracted fraction, standardization, contaminants, and evidence; the word mushroom does not identify a tested intervention.
Read moreProbiotics and Synbiotics During Cancer Treatment: Strain-Specific Evidence
Probiotic effects are strain-, combination-, product-, storage-, and condition-specific, and immune compromise changes the safety conversation.
Read moreNamed profile I’m-Yunity PSP: Canine Product ProfileRepresentative category illustration – no product packaging is shown.I’m-Yunity PSP: Canine Product Profile
I'm-Yunity is a named branded product for Dogs; manufacturer positioning must be kept separate from independent clinical evidence.
Read moreNamed profile Four Leaf Rover Turkey Tail Mushroom: Product ProfileRepresentative category illustration – no product packaging is shown.Four Leaf Rover Turkey Tail Mushroom: Product Profile
Four Leaf Rover Turkey Tail Mushroom is a named branded product for Dogs; manufacturer positioning must be kept separate from independent clinical evidence.
Read moreNamed profile Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence BoundaryRepresentative category illustration – no product packaging is shown.Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence Boundary
temozolomide is covered as triazene antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease ProfileRepresentative category illustration – no product packaging is shown.Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease Profile
hydroxyurea is covered as ribonucleotide-reductase inhibitors; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety ProfileRepresentative category illustration – no product packaging is shown.Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety Profile
procarbazine is covered as methylhydrazine antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History ProfileRepresentative category illustration – no product packaging is shown.Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History Profile
paclitaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more